Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29039833 | 1.00 | FFAR3 (0.78) | — | |
| Acetic Acid SCHEMBL3961679 | 0.95 | — | — | |
| Acetic Acid SCHEMBL28339603 | 0.95 | — | — | |
| Acetic Acid SCHEMBL1632560 | 0.95 | — | — | |
| Acetic Acid SCHEMBL7704933 | 0.95 | — | — | |
| Acetic Acid SCHEMBL11881601 | 0.91 | — | — | |
| Tetrachloroethylene SCHEMBL27902967 | 0.91 | FFAR3 (0.64) | — | |
| Acetic Acid SCHEMBL7359120 | 0.89 | — | — | |
| Acetic Acid SCHEMBL10553195 | 0.89 | — | — | |
| Acetic Acid SCHEMBL6788 | 0.88 | FFAR3 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005780-B2 | Production method of imidazole derivatives | TAKEDA PHARMACEUTICAL COMPANY (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20160244454-A1 | PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICALS CO (JP) | 2016-08-25 | — | — | US | disclosed |
| US-9278938-B2 | Production method of imidazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-03-08 | — | — | US | disclosed |
| CN-103608334-B | The preparation method of imdazole derivatives | TAKEDA PHARMACEUTICAL CO.,LTD. (JP) | 2015-12-23 | — | — | CN | disclosed |
| EP-2721010-B1 | PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICAL (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-2721010-A1 | PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES | Takeda Pharmaceutical Company Limited (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-20140100373-A1 | PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-04-10 | — | — | US | disclosed |
| CN-103608334-A | Production method of imidazole derivatives | TAKAEDA CHEMICAL IND LTD | 2014-02-26 | — | — | CN | disclosed |
| US-8586762-B2 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-11-19 | — | — | US | disclosed |
| WO-2012173280-A1 | PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-12-20 | — | — | WO | disclosed |
| US-20120077985-A1 | PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-29 | — | — | US | disclosed |
| US-8093403-B2 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-01-10 | — | — | US | disclosed |
| EP-2275411-A2 | Reformatsky Reagent in Stable Form and Process for Producing the Same | Takeda Pharmaceutical Company Limited (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100105922-A1 | PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-29 | — | — | US | disclosed |
| US-7662974-B2 | reduction of carboxylic acid ester using metal hydride complexes and metal halides to form compounds such as ethyl (3S)-3-hydroxy-3-{6-[(methylamino)carbonyl]-2-naphthyl}-3-(1-trityl-1H-imidazol-4-yl)propanoate, used as lyase enzyme inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-16 | — | — | US | disclosed |
| CN-100531937-C | Method of sterilization and electrolytic water ejecting apparatus | PERMELEC ELECTRODE LTD (JP) | 2009-08-26 | — | — | CN | disclosed |
| CN-1899975-A | Method of sterilization and electrolytic water ejecting apparatus | PERMELEC ELECTRODE LTD (JP) | 2007-01-24 | — | — | CN | disclosed |
| US-20050043544-A1 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1471056-A1 | PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME | Takeda Chemical Industries, Ltd. (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-4767564-A | 4-BUTYROLACTONE, ETHYLENE GLYCOL MONOMETHYL ETHER ACETATE; SODIUM HYPOCHLORITE SOLUTION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1988-08-30 | — | — | US | disclosed |